Bhuvaneswari Ramaswamy

Bhuvaneswari Ramaswamy

UNVERIFIED PROFILE

Are you Bhuvaneswari Ramaswamy?   Register this Author

Register author
Bhuvaneswari Ramaswamy

Bhuvaneswari Ramaswamy

Publications by authors named "Bhuvaneswari Ramaswamy"

Are you Bhuvaneswari Ramaswamy?   Register this Author

89Publications

1841Reads

13Profile Views

Vandetanib sensitizes head and neck squamous cell carcinoma to photodynamic therapy through modulation of EGFR-dependent DNA repair and the tumour microenvironment.

Photodiagnosis Photodyn Ther 2019 Sep 9;27:367-374. Epub 2019 Jul 9.

Oncology Academic Program, Duke-NUS Medical School, 169857, Singapore; Division of Radiation Oncology, National Cancer Centre Singapore, 169610, Singapore; Division of Medical Sciences, National Cancer Centre Singapore, 169610, Singapore. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pdpdt.2019.06.008DOI Listing
September 2019

The Hedgehog Signaling Pathway: A Viable Target in Breast Cancer?

Cancers (Basel) 2019 Aug 7;11(8). Epub 2019 Aug 7.

Division of Medical Oncology, Department of Internal medicine, James Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11081126DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721501PMC
August 2019

Progression-Free Survival for Real-World Use of Palbociclib in Hormone Receptor-Positive Metastatic Breast Cancer.

Clin Breast Cancer 2019 Jul 17. Epub 2019 Jul 17.

Department of Pharmacy, The Stefanie Spielman Comprehensive Breast Center, The James Cancer Hospital and Solove Research Institute at The Ohio State University Wexner Medical Center, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2019.06.010DOI Listing
July 2019

Spider Telangiectases and Palmar Erythema as Harbingers of Structural Liver Changes in Three Breast Cancer Patients on Ado-trastuzumab Emtansine.

J Clin Aesthet Dermatol 2019 Jul 1;12(7):23-26. Epub 2019 Jul 1.

Drs. Milam and Kaffenberger are with the Division of Dermatology at The Ohio State University Wexner Medical Center in Columbus, Ohio.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715332PMC
July 2019

Pathological complete response rates with pertuzumab-based neoadjuvant chemotherapy in breast cancer: A single-center experience.

J Oncol Pharm Pract 2019 Jun 29:1078155219857800. Epub 2019 Jun 29.

4 The Ohio State University Wexner Medical Center, Division of Medical Oncology, The Stefanie Spielman Comprehensive Breast Center, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155219857800DOI Listing
June 2019

Early Detection of Anthracycline-Induced Cardiotoxicity in Breast Cancer Survivors With T2 Cardiac Magnetic Resonance.

Circ Cardiovasc Imaging 2019 May;12(5):e008777

Division of Medical Oncology, James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus. (M.B.L., R.R., S.C., B.R., R.W., P.B., C.L.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCIMAGING.118.008777DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516083PMC
May 2019

How Long of a Dynamic 3'-Deoxy-3'-[F]fluorothymidine ([F]FLT) PET Acquisition Is Needed for Robust Kinetic Analysis in Breast Cancer?

Mol Imaging Biol 2019 04;21(2):382-390

Wright Center of Innovation in Biomedical Imaging, Department of Radiology, The Ohio State University Wexner Medical Center, 395 W. 12th Avenue, Room 430, Columbus, OH, 43210-1228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11307-018-1231-xDOI Listing
April 2019

Targeting Tissue Factor for Immunotherapy of Triple-Negative Breast Cancer Using a Second-Generation ICON.

Cancer Immunol Res 2018 06 5;6(6):671-684. Epub 2018 Apr 5.

Department of Surgery Division of Surgical Oncology, The Ohio State University Wexner Medical Center and The OSU James Comprehensive Cancer Center, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-17-0343DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984705PMC
June 2018

Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102.

J Clin Oncol 2018 06 17;36(16):1556-1563. Epub 2018 Apr 17.

Noah Kornblum, Della F. Makower, and Joseph A. Sparano, Albert Einstein College of Medicine, Bronx; Paula Klein, Mount Sinai Beth Israel Comprehensive Cancer Center, New York, NY; Fengmin Zhao and Judith Manola, Dana-Farber Cancer Institute, Boston, MA; Bhuvaneswari Ramaswamy, The Ohio State University Comprehensive Cancer Center, Columbus, OH; Adam Brufsky, University of Pittsburgh, Pittsburgh; Cristina I. Truica, Penn State Cancer Institute, Hershey; Lori J. Goldstein, Fox Chase Cancer Center, Philadelphia, PA; Phillip J. Stella, Saint Joseph Mercy (Michigan Cancer Consortium), Ann Arbor, MI; Brian Burnette, Saint Vincent Hospital, Green Bay; Timothy R. Wassenaar, Pro Health Care, Waukesha, WI; Melinda Telli, Stanford University School of Medicine, Stanford, CA; Puneet Cheema, Metro-Minnesota Community Oncology Research Consortium, Saint Louis Park, MN; Antonio C. Wolff, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Gamini S. Soori, Missouri Valley Cancer Consortium, Omaha, NE; Barbara Haley, UT Southwestern Medical Center, Dallas, TX; and Kathy D. Miller, Indiana University School of Medicine, Indianapolis, IN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.9331DOI Listing
June 2018

Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients.

Breast Cancer Res Treat 2017 Jul 3;164(1):69-77. Epub 2017 Apr 3.

Division of Medical Oncology, Stefanie Spielman Comprehensive Breast Center, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4230-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510549PMC
July 2017

Discovery of Stromal Regulatory Networks that Suppress Ras-Sensitized Epithelial Cell Proliferation.

Dev Cell 2017 05;41(4):392-407.e6

Solid Tumor Biology Program, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA; Department of Molecular Genetics, The Ohio State University, 484 West 12th Avenue, Columbus, OH 43210, USA; Department of Cancer Biology and Genetics, McGill University, Montreal, QC H3A 1A1, Canada; Hollings Cancer Center, Medical University of South Carolina, Hollings Cancer Center 124J, 86 Jonathan Lucas Street, Charleston, SC 29425, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.devcel.2017.04.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508591PMC
May 2017

A Comprehensive Program for the Enhancement of Accrual to Clinical Trials.

Ann Surg Oncol 2016 07 20;23(7):2146-52. Epub 2016 Jan 20.

Department of Surgery, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-016-5091-9DOI Listing
July 2016

Novel delivery of Chlorin e6 using anti-EGFR antibody tagged virosomes for fluorescence diagnosis of oral cancer in a hamster cheek pouch model.

Eur J Pharm Sci 2016 Feb 18;83:143-54. Epub 2015 Dec 18.

Division of Medical Sciences, National Cancer Centre Singapore, 11 Hospital Drive, 169610, Singapore; Office of Research, Duke-NUS Graduate Medical School, 8 College Road, 169857, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejps.2015.12.023DOI Listing
February 2016

Palbociclib: A Novel Cyclin-Dependent Kinase Inhibitor for Hormone Receptor-Positive Advanced Breast Cancer.

Ann Pharmacother 2015 Nov 31;49(11):1252-60. Epub 2015 Aug 31.

The James Cancer Hospital at the Ohio State University, Columbus, OH, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1060028015602273DOI Listing
November 2015

Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction.

Support Care Cancer 2015 Jul 18;23(7):2019-24. Epub 2014 Dec 18.

Pharmacy Department, The Stefanie Spielman Comprehensive Breast Center, The James Cancer Hospital and Solove Research Institute at the Ohio State University, Columbus, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-014-2556-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804339PMC
July 2015

Nimotuzumab increases the anti-tumor effect of photodynamic therapy in an oral tumor model.

Oncotarget 2015 May;6(15):13487-505

National Cancer Centre Singapore, Division of Medical Sciences, Singapore 169610, Singapore.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537029PMC
http://dx.doi.org/10.18632/oncotarget.3622DOI Listing
May 2015

A Phase II study of bevacizumab in combination with trastuzumab and docetaxel in HER2 positive metastatic breast cancer.

Invest New Drugs 2014 Dec 5;32(6):1285-94. Epub 2014 Jun 5.

Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, The Ohio State University's Wexner Medical Center, Starling-Loving Hall, 320 W 10th Ave, Columbus, OH, 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-014-0122-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303337PMC
December 2014

Phase II trial of neoadjuvant weekly nanoparticle albumin-bound paclitaxel, carboplatin, and biweekly bevacizumab therapy in women with clinical stage II or III HER2-negative breast cancer.

Clin Breast Cancer 2014 Aug 20;14(4):228-34. Epub 2014 Feb 20.

Division of Medical Oncology, The Ohio State University Medical Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2014.02.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104207PMC
August 2014

Mechanisms and therapeutic advances in the management of endocrine-resistant breast cancer.

World J Clin Oncol 2014 Aug;5(3):248-62

Meng Zhao, Bhuvaneswari Ramaswamy, Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, The Ohio State University's Wexner Medical Center, Columbus, OH 43210, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5306/wjco.v5.i3.248DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127598PMC
August 2014

Docetaxel-induced skin toxicities in breast cancer patients subsequent to paclitaxel shortage: a case series and literature review.

Support Care Cancer 2013 Oct 19;21(10):2679-86. Epub 2013 May 19.

Department of Pharmacy, The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, 300 W 10th Ave, Columbus, OH, 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-013-1842-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769512PMC
October 2013

Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancer.

Cancer Chemother Pharmacol 2013 May 21;71(5):1183-90. Epub 2013 Feb 21.

Division of Medical Oncology, Stefanie Spielman Comprehensive Breast Center, The Ohio State University Comprehensive Cancer Center, B411 Starling Loving Hall, 320 West 10th Avenue, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-013-2112-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710373PMC
May 2013

Assessment of γ-H2AX levels in circulating tumor cells from patients receiving chemotherapy.

Front Oncol 2012 25;2:128. Epub 2012 Oct 25.

William G. Lowrie Department of Chemical and Biomolecular Engineering, The Ohio State University Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2012.00128DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480704PMC
November 2012

Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway.

Cancer Res 2012 Oct 8;72(19):5048-59. Epub 2012 Aug 8.

Department of Molecular and Cellular Biochemistry, The Ohio State University, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-12-1248DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837449PMC
October 2012

Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes.

Cancer Chemother Pharmacol 2012 Jul 22;70(1):49-56. Epub 2012 May 22.

Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, B421 Starling-Loving Hall, 320 West 10th Avenue, Columbus, OH 43210-1240, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00280-012-1887-x
Publisher Site
http://dx.doi.org/10.1007/s00280-012-1887-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3466596PMC
July 2012

Phase II trial of exemestane in combination with fulvestrant in postmenopausal women with advanced, hormone-responsive breast cancer.

Clin Breast Cancer 2012 Apr;12(2):151-6

Division of Medical Oncology, The Ohio State University Medical Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2012.01.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003403PMC
April 2012

Highly sensitive SERS detection of cancer proteins in low sample volume using hollow core photonic crystal fiber.

Biosens Bioelectron 2012 Mar 4;33(1):293-8. Epub 2012 Jan 4.

Bio-Optical Imaging Group, Singapore Bioimaging Consortium, Agency for Science Technology and Research (A*STAR), 11 Biopolis Way, Singapore 138667, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bios.2011.12.056DOI Listing
March 2012

Gene expression profiling: changing face of breast cancer classification and management.

Gene Expr 2011 ;15(3):105-15

Division of Medical Oncology, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772713PMC
February 2012

Pregnancy-associated breast cancer.

Clin Obstet Gynecol 2011 Dec;54(4):546-55

Division of Medical Oncology, Arthur G. James Cancer Hospital, Richard J. Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/GRF.0b013e318236e436DOI Listing
December 2011

Photolon™ --photosensitization induces apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes.

Int J Oncol 2011 Oct 1;39(4):821-31. Epub 2011 Jul 1.

Division of Medical Science, National Cancer Centre Singapore, 169610 Singapore.

View Article

Download full-text PDF

Source
http://www.spandidos-publications.com/10.3892/ijo.2011.1109
Publisher Site
http://dx.doi.org/10.3892/ijo.2011.1109DOI Listing
October 2011

Antiangiogenesis agents avastin and erbitux enhance the efficacy of photodynamic therapy in a murine bladder tumor model.

Lasers Surg Med 2011 Sep;43(7):651-62

National Cancer Centre Singapore, 11 Hospital Drive, Singapore 169610, Singapore.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/lsm.21109
Publisher Site
http://dx.doi.org/10.1002/lsm.21109DOI Listing
September 2011

Phase II trial of neoadjuvant exemestane in combination with celecoxib in postmenopausal women who have breast cancer.

Clin Breast Cancer 2011 Aug 19;11(4):221-7. Epub 2011 May 19.

Comprehensive Breast Health Services of the Ohio State University Medical Center, and James Cancer Hospital, 320 West 10th Avenue, Columbus OH 43210-1240, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2011.03.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440773PMC
August 2011

Advances in bio-optical imaging for the diagnosis of early oral cancer.

Pharmaceutics 2011 Jul 11;3(3):354-78. Epub 2011 Jul 11.

School of Physics, National University of Ireland Galway, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/pharmaceutics3030354DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857071PMC
July 2011

Ultrasensitive near-infrared Raman reporters for SERS-based in vivo cancer detection.

Angew Chem Int Ed Engl 2011 Jun 17;50(27):6089-92. Epub 2011 May 17.

Department of Chemistry & MedChem Program of Life Sciences Institute, National University of Singapore, Singapore, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/anie.201007841DOI Listing
June 2011

Phase II trial of pyrazoloacridine (NSC#366140) in patients with metastatic breast cancer.

Invest New Drugs 2011 Apr 21;29(2):347-51. Epub 2009 Oct 21.

Division of Hematology and Oncology, Ohio State University Medical Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-009-9338-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3486428PMC
April 2011

Epigenetic silencing mediated through activated PI3K/AKT signaling in breast cancer.

Cancer Res 2011 Mar 7;71(5):1752-62. Epub 2011 Jan 7.

Human Cancer Genetics Program, Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-3573DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048165PMC
March 2011

Epigenetic Therapy in Breast Cancer.

Curr Breast Cancer Rep 2011 Mar;3(1):34-43

Division of Hematology and Oncology, Comprehensive Cancer Center, The Ohio State University Medical Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12609-010-0034-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477864PMC
March 2011

Chlorin e6-polyvinylpyrrolidone mediated photodynamic therapy--A potential bladder sparing option for high risk non-muscle invasive bladder cancer.

Photodiagnosis Photodyn Ther 2010 Dec 29;7(4):213-20. Epub 2010 Sep 29.

Department of Urology, Singapore General Hospital, Outram Road, 169608, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pdpdt.2010.08.005DOI Listing
December 2010

Development of biocompatible SERS nanotag with increased stability by chemisorption of reporter molecule for in vivo cancer detection.

Biosens Bioelectron 2010 Oct 5;26(2):398-403. Epub 2010 Aug 5.

Singapore Bioimaging Consortium, Agency for Science, Technology and Research (A*STAR), 11 Biopolis Way, Singapore 138667, Republic of Singapore.

View Article

Download full-text PDF

Source
http://ytchang.science.nus.edu.sg/pages/reprint/2010_Biosens
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S095656631000498
Publisher Site
http://dx.doi.org/10.1016/j.bios.2010.07.123DOI Listing
October 2010

Ixabepilone as monotherapy or in combination for the treatment of advanced breast cancer.

Breast Cancer (Dove Med Press) 2010 May 24;2:13-23. Epub 2010 May 24.

Department of Internal Medicine, Division of Hematology-Oncology, The Ohio State University Medical Center, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846877PMC
May 2010

Targeted Therapy of Cancer Using Photodynamic Therapy in Combination with Multi-faceted Anti-Tumor Modalities.

Pharmaceuticals (Basel) 2010 May 14;3(5):1507-1529. Epub 2010 May 14.

National Cancer Centre Singapore, 11 Hospital Drive, 169610, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ph3051507DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033994PMC
May 2010

The effect of photodynamic therapy on tumor angiogenesis.

Cell Mol Life Sci 2009 Jul 31;66(14):2275-83. Epub 2009 Mar 31.

National Cancer Centre Singapore, 11 Hospital Drive, Singapore.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00018-009-0016-4
Publisher Site
http://dx.doi.org/10.1007/s00018-009-0016-4DOI Listing
July 2009

Association of major stressors with elevated risk of breast cancer incidence or relapse.

Drugs Today (Barc) 2009 Feb;45(2):115-26

Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Ohio State University, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1358/dot.2009.45.2.1322480DOI Listing
February 2009

MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1.

J Biol Chem 2008 Oct 15;283(44):29897-903. Epub 2008 Aug 15.

Department of Molecular and Cellular Biochemistry, College of Medicine, Ohio State University, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M804612200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2573063PMC
October 2008

Immune response against angiosarcoma following lower fluence rate clinical photodynamic therapy.

J Environ Pathol Toxicol Oncol 2008 ;27(1):35-42

Division of Medical Sciences, National Cancer Centre, Singapore.

View Article

Download full-text PDF

Source
June 2008

Docetaxel for the post-surgery treatment of patients with node-positive breast cancer.

Ther Clin Risk Manag 2008 Apr;4(2):419-24

Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Ohio State University Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2504077PMC
http://dx.doi.org/10.2147/tcrm.s1766DOI Listing
April 2008

Hypericin-mediated photodynamic therapy in combination with Avastin (bevacizumab) improves tumor response by downregulating angiogenic proteins.

Photochem Photobiol Sci 2007 Dec 5;6(12):1275-83. Epub 2007 Nov 5.

National Cancer Centre Singapore, 11 Hospital Drive, Singapore 169610.

View Article

Download full-text PDF

Source
http://xlink.rsc.org/?DOI=b705763f
Publisher Site
http://dx.doi.org/10.1039/b705763fDOI Listing
December 2007

Chlorin e6-polyvinylpyrrolidone as a fluorescent marker for fluorescence diagnosis of human bladder cancer implanted on the chick chorioallantoic membrane model.

Cancer Lett 2007 Jan 3;245(1-2):127-33. Epub 2006 Mar 3.

Division of Medical Sciences, National Cancer Centre Singapore, 11 Hospital Drive, Singapore 169610, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2005.12.041DOI Listing
January 2007

The potential application of chlorin e6-polyvinylpyrrolidone formulation in photodynamic therapy.

Photochem Photobiol Sci 2006 Nov 21;5(11):1031-7. Epub 2006 Sep 21.

Division of Medical Sciences, National Cancer Centre Singapore, 11 Hospital Drive, 169610, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/b605772aDOI Listing
November 2006

Fluorescence imaging and phototoxicity effects of new formulation of chlorin e6-polyvinylpyrrolidone.

J Photochem Photobiol B 2006 Aug 20;84(2):103-10. Epub 2006 Mar 20.

Division of Medical Sciences, National Cancer Centre Singapore, 11 Hospital Drive, Singapore 169610, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jphotobiol.2006.02.002DOI Listing
August 2006

Phase II study of weekly docetaxel and capecitabine in patients with metastatic breast cancer.

Clin Breast Cancer 2006 Jun;7(2):141-5

Division of Hematology and Oncology, Comprehensive Cancer Center, Ohio State University Medical Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CBC.2006.n.023DOI Listing
June 2006

Docetaxel: a tubulin-stabilizing agent approved for the management of several solid tumors.

Drugs Today (Barc) 2006 Apr;42(4):265-79

Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1358/dot.2006.42.4.968648DOI Listing
April 2006

Phase II trial of neoadjuvant chemotherapy with docetaxel followed by epirubicin in stage II/III breast cancer.

Breast Cancer Res Treat 2005 Sep;93(1):67-74

Division of Hematology/Oncology and Comprehensive Breast Health Services, Ohio State University Medical Center, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-005-3784-zDOI Listing
September 2005

Photodynamic diagnosis of a human nasopharyngeal carcinoma xenograft model using the novel Chlorin e6 photosensitizer Fotolon.

Int J Oncol 2005 Jun;26(6):1501-6

Division of Medical Sciences, National Cancer Centre Singapore, Singapore 169610.

View Article

Download full-text PDF

Source
June 2005

Osteopenia and osteoporosis in women with breast cancer.

Semin Oncol 2003 Dec;30(6):763-75

Department of Medicine, Ohio State University Medical Center and Comprehensive Cancer Center, Columbus 43210, USA.

View Article

Download full-text PDF

Source
December 2003

Phase II trial of bevacizumab in combination with docetaxel in women with advanced breast cancer.

Clin Breast Cancer 2003 Oct;4(4):292-4

The Ohio State University Medical Center and Comprehensive Cancer Center, Columbus 43210, USA.

View Article

Download full-text PDF

Source
October 2003

Bisphosphonates in the prevention and treatment of bone metastases.

Oncology (Williston Park) 2003 Sep;17(9):1261-70; discussion 1270-2, 1277-8, 1280

Ohio State University Medical Center, Comprehensive Cancer Center, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
September 2003